WIIK PHARMA ApS Financials, key figures and credit report
Gross profit 7 105.6 kDKK FY 2025 -19.5% vs 2024
EBIT 2 554.2 kDKK FY 2025 -54.1% vs 2024
Net debt -6 089.3 kDKK FY 2025 +10.5% vs 2024
Quick ratio 1.7 FY 2025 +0.1 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 3 172.30 | 4 087.84 | 6 666.20 | 8 830.51 | 7 105.58 |
| Employee benefit expenses | -1 829.69 | -2 708.93 | -2 940.07 | -3 262.02 | -4 422.71 |
| Total depreciation | - 128.64 | ||||
| EBIT | 1 342.60 | 1 378.90 | 3 726.13 | 5 568.49 | 2 554.23 |
| Other financial income | 0.13 | 22.81 | 97.33 | 88.26 | 153.97 |
| Other financial expenses | -59.47 | -71.07 | - 230.86 | -29.16 | - 116.70 |
| Pre-tax profit | 1 283.27 | 1 330.64 | 3 592.59 | 5 627.59 | 2 591.51 |
| Income taxes | - 285.05 | - 299.54 | - 796.47 | -1 242.40 | - 566.79 |
| Net earnings | 998.21 | 1 031.11 | 2 796.13 | 4 385.19 | 2 024.72 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 543.40 | ||||
| Tangible assets total | 543.40 | ||||
| Participating interests | 692.30 | 2 558.03 | |||
| Investments total | 30.73 | 21.60 | 23.60 | 716.05 | 2 595.77 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 1 301.41 | 1 636.30 | 3 813.82 | 4 060.24 | 1 784.81 |
| Current amounts owed by group member comp. | 3.47 | 3.61 | 1 344.11 | 545.79 | 945.39 |
| Prepayments and accrued income | 18.09 | ||||
| Current other receivables | 6.75 | 0.58 | 31.29 | ||
| Short term receivables total | 1 304.88 | 1 639.91 | 5 164.68 | 4 624.70 | 2 761.50 |
| Cash and bank deposits | 3 161.71 | 3 201.09 | 4 146.23 | 6 809.07 | 6 091.71 |
| Cash and cash equivalents | 3 161.71 | 3 201.09 | 4 146.23 | 6 809.07 | 6 091.71 |
| Balance sheet total (assets) | 4 497.33 | 4 862.60 | 9 334.51 | 12 149.82 | 11 992.38 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 995.00 | 1 000.00 | 2 596.00 | 2 300.00 | |
| Retained earnings | - 978.69 | - 980.48 | -2 545.37 | 250.76 | 2 335.95 |
| Profit of the financial year | 998.21 | 1 031.11 | 2 796.13 | 4 385.19 | 2 024.72 |
| Shareholders equity total | 1 064.52 | 1 100.63 | 2 896.76 | 4 685.95 | 6 710.67 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 34.61 | 5.65 | 2.41 | ||
| Advances received | 59.49 | ||||
| Current trade creditors | 1 715.41 | 1 988.03 | 3 810.32 | 4 819.75 | 2 982.77 |
| Current owed to group member | 251.00 | 188.29 | |||
| Short-term deferred tax liabilities | 285.05 | 299.54 | 796.47 | 1 242.40 | 566.79 |
| Other non-interest bearing current liabilities | 1 121.85 | 1 251.50 | 1 830.96 | 1 396.06 | 1 729.74 |
| Current liabilities total | 3 432.81 | 3 761.97 | 6 437.75 | 7 463.86 | 5 281.71 |
| Balance sheet total (liabilities) | 4 497.33 | 4 862.60 | 9 334.51 | 12 149.82 | 11 992.38 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated